SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-23-028428
Filing Date
2023-03-03
Accepted
2023-03-03 16:14:28
Documents
12
Period of Report
2023-02-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm237887d1_8k.htm   iXBRL 8-K 29386
  Complete submission text file 0001104659-23-028428.txt   204801

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA ruby-20230227.xsd EX-101.SCH 3033
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE ruby-20230227_lab.xml EX-101.LAB 34476
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ruby-20230227_pre.xml EX-101.PRE 22595
6 EXTRACTED XBRL INSTANCE DOCUMENT tm237887d1_8k_htm.xml XML 3645
Mailing Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035
Business Address C/O VERDOLINO & LOWEY, P.C. 124 WASHINGTON STREET, SUITE 101 FOXBORO MA 02035 617-679-9600
Rubius Therapeutics, Inc. (Filer) CIK: 0001709401 (see all company filings)

IRS No.: 042688109 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38586 | Film No.: 23704110
SIC: 2836 Biological Products, (No Diagnostic Substances)